SCHEMBL21804756

SCHEMBL21804756

CC(C)(C)OC(=O)CCC(N)(CCC(=O)O)C(C(C(=O)ON)C(C)(C)C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4408680 0.88 MEN1 (0.32)
Ammonia Solution, Strong SCHEMBL28609530 0.87 MEN1 (0.31)
SCHEMBL25334575 0.72 ALDH1A1 (0.41)
SCHEMBL29392985 0.69 MEN1 (0.35)
SCHEMBL15486172 0.69 NAALAD2 (0.32)
SCHEMBL16317409 0.69 NAALAD2 (0.38)
SCHEMBL17502001 0.68
SCHEMBL16334546 0.65 STING1 (0.36)
SCHEMBL328633 0.65 STING1 (0.36)
SCHEMBL3960043 0.65 GRM4 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11541122-B2 Glucose sensitive insulins and uses thereof ZIYLO LIMITED 2023-01-03 US disclosed
US-20220047708-A1 GLUCOSE SENSITIVE INSULINS AND USES THEREOF NOVO NORDISK RESEARCH CENTRE OXFORD LIMITED (GB) 2022-02-17 US disclosed
EP-3852873-A1 GLUCOSE SENSITIVE INSULINS AND USES THEREOF Ziylo Ltd (GB) 2021-07-28 EP disclosed
WO-2020058322-A1 GLUCOSE SENSITIVE INSULINS AND USES THEREOF ZIYLO LTD. (GB) 2020-03-26 WO disclosed